8-K: Current report
10-Q: Quarterly report
424B5: Prospectus
424B5: Prospectus
EFFECT: Others
S-3/A: Registration statement for specified transactions by certain issuers (Amendment)
S-3: Registration statement for specified transactions by certain issuers
Lixte Biotechnology | 8-K: Current report
Lixte Biotechnology | 8-K: Current report
Lixte Biotechnology | 10-K: Annual report
Lixte Biotechnology | 8-K: Current report
Lixte Biotechnology | 8-K: Current report
Lixte Biotechnology | 8-K: Current report
Lixte Biotechnology | 8-K: Current report
Lixte Biotechnology | 8-K: Current report
Lixte Biotechnology: Q3 2023 Earnings Report
Lixte Biotechnology | 8-K: Current report
Lixte Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer van der Baan Bastiaan Jeroen
Lixte Biotechnology | DEFA14A: Others
Lixte Biotechnology | DEF 14A: Definitive information statements
No Data